510(k) K253490

Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions by Roche Diagnostics — Product Code CFR

K253490 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions". The FDA issued a decision of Substantially Equivalent on February 12, 2026. The device falls under product code CFR (Hexokinase, Glucose), a Class II device regulated under 21 CFR 862.1345. Roche Diagnostics has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 12, 2026
Date Received
October 24, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Hexokinase, Glucose
Device Class
Class II
Regulation Number
862.1345
Review Panel
CH
Submission Type